SAS Output

20-AUG-2018 6:10

MMYEL ACCRUAL REPORT - Open and Recently Closed Studies

The REPORT Procedure

Detailed and/or summarized report

Table 1

SWOG/
Support
STUDY R
E
G
O
P
E
N
ARM ACCR.
GOAL
TOTAL
REGS.
REGS.
LAST
12
Month
REGS.
LAST
6
Month
REGS.
LAST
3
Month
REGS.
LAST
30
DAYS
REGS.
LAST
7
DAYS
DATE OF
FIRST
REG.
# of
ACT.
INSTs
# of
CURR
IRBs
SWOG S1304-MM,relapsed/refractory, Car+Dex 1 N 1 Dex+Low Dose Carfilzomib 140 72 0 0 0 0 0 02/12/2014 13 1
        2 Dex+High Dose Carfilzomib   71 0 0 0 0 0      
            143 0 0 0 0 0      
 
    2 Y 3 Dex+High Dose Carfilzomib 140 22 0 0 0 0 0 02/12/2014    
            22 0 0 0 0 0      
 
  S1702-AL Amyloidosis, Relapsed, Isatuximab 1 Y 1 Isatuximab 39 4 4 4 4 1 0 06/06/2018 138 49
            4 4 4 4 1 0      
 
  S0777-MM, Len Dex +/- Bortezomib 1 N 1 Lenalidomide/Dex 484 261 0 0 0 0 0 07/28/2008    
        2 Bortezomib/Lenalidomide/Dex   264 0 0 0 0 0      
            525 0 0 0 0 0      
 
Yes E1A11-MM, frontline, BLD vs CLD 1 E Total Registrations   210 80 33 6 3 0 03/05/2014   144
            210 80 33 6 3 0      
 
No A061402-Solitary Plasmacytoma, adj sys+Zol vs Zol 0 E Total Registrations   1 0 0 0 0 0 01/27/2017    
            1 0 0 0 0 0      
 
  E1A11-MM, frontline, BLD vs CLD 0 E Total Registrations   235 94 41 9 4 2 03/05/2014   144
            235 94 41 9 4 2      
 
    2 E Total Registrations   66 30 13 5 1 1 03/05/2014    
            66 30 13 5 1 1      
 

20-AUG-2018 6:10

MMYEL Open Studies with No Registrations

The REPORT Procedure

Detailed and/or summarized report

Table 1

Study Registration/Phase Open Date
S0777 MM, Len Dex +/- Bortezomib 2 Autologous Transplant 01-Apr-08